With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free generic EpiPens to ...

Amneal Gets FDA Nod for Parkinson’s Disease Drug In August 2024, the FDA approved Amneal’s IPX203, a novel, oral formulation ...

A pharmaceutical corporation sued Colorado Friday in federal court aiming to bring a halt to a law approved in 2023, which ...

Comprehensive access and affordability services to be made available to Parkinson’s patients and healthcare providers Amneal to hold CREXONT launch symposium and scientific presentations at the ...

Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.52 which represents a decrease of $-0.18 or -2.07% from the prior close of $8.7. The stock opened at $8.67 and touched a low ...

Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and ...